Autologous TLPO Vaccine Basket

Clinical trial NCT06175221 · TERMINATED

Trial details

NCT number: NCT06175221
Sponsor: Elios Therapeutics, LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Tumor, Solid Tumor Metastasis Cancer Tumor

Start date: 2023-11-29
Primary completion: 2025-07-02
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.